Feitelson MA - Search Results

1

Functional inactivation but not structural mutation of p53 causes liver cancer.

Ueda H, Ullrich SJ, Gangemi JD, Kappel CA, Ngo L, Feitelson MA, Jay G. Ueda H, et al. Among authors: feitelson ma. Nat Genet. 1995 Jan;9(1):41-7. doi: 10.1038/ng0195-41. Nat Genet. 1995. PMID: 7704023

2

Aflatoxin B1-DNA adducts and hepatitis B virus antigens in hepatocellular carcinoma and non-tumorous liver tissue.

Zhang YJ, Chen CJ, Lee CS, Haghighi B, Yang GY, Wang LW, Feitelson M, Santella R. Zhang YJ, et al. Carcinogenesis. 1991 Dec;12(12):2247-52. doi: 10.1093/carcin/12.12.2247. Carcinogenesis. 1991. PMID: 1721008

3

Inhibitory effect of tumor suppressor p33(ING1b) and its synergy with p53 gene in hepatocellular carcinoma.

Zhu Z, Lin J, Qu JH, Feitelson MA, Ni CR, Li FM, Zhu MH. Zhu Z, et al. Among authors: feitelson ma. World J Gastroenterol. 2005 Apr 7;11(13):1903-9. doi: 10.3748/wjg.v11.i13.1903. World J Gastroenterol. 2005. PMID: 15800978 Free PMC article.

4

4-Aminobiphenyl DNA damage in liver tissue of hepatocellular carcinoma patients and controls.

Wang LY, Chen CJ, Zhang YJ, Tsai WY, Lee PH, Feitelson MA, Lee CS, Santella RM. Wang LY, et al. Among authors: feitelson ma. Am J Epidemiol. 1998 Feb 1;147(3):315-23. doi: 10.1093/oxfordjournals.aje.a009452. Am J Epidemiol. 1998. PMID: 9482507

5

Immunohistochemical detection of aflatoxin B1-DNA adducts and hepatitis B virus antigens in hepatocellular carcinoma and nontumorous liver tissue.

Santella RM, Zhang YJ, Chen CJ, Hsieh LL, Lee CS, Haghighi B, Yang GY, Wang LW, Feitelson M. Santella RM, et al. Environ Health Perspect. 1993 Mar;99:199-202. doi: 10.1289/ehp.9399199. Environ Health Perspect. 1993. PMID: 8391434 Free PMC article.

6

COOH-terminal deletion of HBx gene is a frequent event in HBV-associated hepatocellular carcinoma.

Liu XH, Lin J, Zhang SH, Zhang SM, Feitelson MA, Gao HJ, Zhu MH. Liu XH, et al. Among authors: feitelson ma. World J Gastroenterol. 2008 Mar 7;14(9):1346-52. doi: 10.3748/wjg.14.1346. World J Gastroenterol. 2008. PMID: 18322946 Free PMC article.

7

Hepatitis-B x-antigen in the pathogenesis of hepatocellular-carcinoma (review).

Feitelson M. Feitelson M. Oncol Rep. 1995 Mar;2(2):193-202. Oncol Rep. 1995. PMID: 21597712

8

Alcohol, hepatotropic viruses, and hepatocellular carcinoma.

Nalpas B, Feitelson M, Bréchot C, Rubin E. Nalpas B, et al. Alcohol Clin Exp Res. 1995 Oct;19(5):1089-95. doi: 10.1111/j.1530-0277.1995.tb01585.x. Alcohol Clin Exp Res. 1995. PMID: 8561275 Review. No abstract available.

9

TMEM43 promotes the development of hepatocellular carcinoma by activating VDAC1 through USP7 deubiquitination.

Zhang N, Wang F, Yang X, Wang Q, Chang R, Zhu L, Feitelson MA, Chen Z. Zhang N, et al. Among authors: feitelson ma. Transl Gastroenterol Hepatol. 2024 Jan 25;9:9. doi: 10.21037/tgh-23-108. eCollection 2024. Transl Gastroenterol Hepatol. 2024. PMID: 38317750 Free PMC article.

10

Editorial: Microbiome metabolites in health and disease.

Canfora EE, Feitelson MA, Arzumanyan A. Canfora EE, et al. Among authors: feitelson ma. Front Microbiol. 2023 Sep 12;14:1270001. doi: 10.3389/fmicb.2023.1270001. eCollection 2023. Front Microbiol. 2023. PMID: 37771705 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114 results

Search Page